Pregnancy in special populations: challenges and solutions practical aspects of managing von Willebrand disease in pregnancy
Pregnancy and childbirth pose an important hemostatic challenge for women with von Willebrand disease (VWD) and can be associated with an increased risk of maternal and neonatal bleeding complications. VWD is a genetically and clinically heterogeneous bleeding disorder caused by a deficiency or an a...
Gespeichert in:
| Veröffentlicht in: | Hematology 2021-12, Vol.2021 (1), p.552-558 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 558 |
|---|---|
| container_issue | 1 |
| container_start_page | 552 |
| container_title | Hematology |
| container_volume | 2021 |
| creator | Turan, Ozlem Kadir, Rezan Abdul |
| description | Pregnancy and childbirth pose an important hemostatic challenge for women with von Willebrand disease (VWD) and can be associated with an increased risk of maternal and neonatal bleeding complications. VWD is a genetically and clinically heterogeneous bleeding disorder caused by a deficiency or an abnormality in the function of von Willebrand factor. Understanding inheritance pattern, hemostatic response to pregnancy, and response to treatment is essential for provision of individualized obstetric care and optimal outcome. A multidisciplinary approach to management with a close liaison between the obstetric team and the hemophilia treatment center is required for continuity of care from preconception counseling through to antenatal, peripartum, and postpartum care. Delivery plan must be coordinated by the multidisciplinary team and include decisions on place and mode of delivery, implementation of safe analgesia/anesthesia, and peripartum hemostasis. In this clinical case-based review, we aim to deliver evidence-based practical guidance for challenges encountered during pregnancy and management of childbirth and puerperium. |
| doi_str_mv | 10.1182/hematology.2021000321 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_webof</sourceid><recordid>TN_cdi_webofscience_primary_000731207900071</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2608540768</sourcerecordid><originalsourceid>FETCH-LOGICAL-c411t-f08d1dd3395960cb470e8982742853b0c08b732454627f715a52067e5086e4273</originalsourceid><addsrcrecordid>eNqNkU9v1DAQxSMEoqXwEUA-IqEt4z-JbQ5I1YoCUiU4gDhajjPJGjl2iJOilfjwTbrtFm6cPNL83ntjvaJ4SeGcUsXe7rC3Uwqp258zYBQAOKOPilNaMtgIrvjj46zpSfEs558AVHDGnhYnXCilBdWnxZ-vI3bRRrcnPpI8oPM2kCENc7CTTzG_I25nQ8DYYSY2NiSnMN9uyDBaN3m38HYVTpmklvQ22s7HjlynSH74RVmPq6zxGW3GNWW4j3xePGltyPji7j0rvl9--Lb9tLn68vHz9uJq4wSl06YF1dCm4VyXugJXCwmotGJSMFXyGhyoWnImSlEx2Upa2uXflcQSVIWCSX5WvD_4DnPdY-MwTqMNZhh9b8e9SdabfzfR70yXro2SmoLWi8HrO4Mx_ZoxT6b32WEINmKas2EVqFKArNSClgfUjSnnEdtjDAWzNmcemjMPzS26V3_feFTdV7UAbw7Ab6xTm53H6PCILS6SUwZSr9Nqp_6f3vrptuxtmuPEbwBSg7qu</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2608540768</pqid></control><display><type>article</type><title>Pregnancy in special populations: challenges and solutions practical aspects of managing von Willebrand disease in pregnancy</title><source>MEDLINE</source><source>Web of Science - Science Citation Index Expanded - 2021<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /></source><source>PubMed Central</source><creator>Turan, Ozlem ; Kadir, Rezan Abdul</creator><creatorcontrib>Turan, Ozlem ; Kadir, Rezan Abdul</creatorcontrib><description>Pregnancy and childbirth pose an important hemostatic challenge for women with von Willebrand disease (VWD) and can be associated with an increased risk of maternal and neonatal bleeding complications. VWD is a genetically and clinically heterogeneous bleeding disorder caused by a deficiency or an abnormality in the function of von Willebrand factor. Understanding inheritance pattern, hemostatic response to pregnancy, and response to treatment is essential for provision of individualized obstetric care and optimal outcome. A multidisciplinary approach to management with a close liaison between the obstetric team and the hemophilia treatment center is required for continuity of care from preconception counseling through to antenatal, peripartum, and postpartum care. Delivery plan must be coordinated by the multidisciplinary team and include decisions on place and mode of delivery, implementation of safe analgesia/anesthesia, and peripartum hemostasis. In this clinical case-based review, we aim to deliver evidence-based practical guidance for challenges encountered during pregnancy and management of childbirth and puerperium.</description><identifier>ISSN: 1520-4391</identifier><identifier>EISSN: 1520-4383</identifier><identifier>DOI: 10.1182/hematology.2021000321</identifier><identifier>PMID: 34889419</identifier><language>eng</language><publisher>WASHINGTON: Amer Soc Hematology</publisher><subject>Adult ; Delivery, Obstetric ; Disease Management ; Education & Educational Research ; Education, Scientific Disciplines ; Female ; Hematology ; Humans ; Life Sciences & Biomedicine ; Pregnancy ; Pregnancy Complications, Hematologic - blood ; Pregnancy Complications, Hematologic - diagnosis ; Pregnancy Complications, Hematologic - therapy ; Pregnancy in Special Populations: Challenges and Solutions ; Pregnancy Outcome ; Science & Technology ; Social Sciences ; von Willebrand Diseases - blood ; von Willebrand Diseases - diagnosis ; von Willebrand Diseases - therapy ; Young Adult</subject><ispartof>Hematology, 2021-12, Vol.2021 (1), p.552-558</ispartof><rights>Copyright © 2021 by The American Society of Hematology.</rights><rights>Copyright © 2021 by The American Society of Hematology 2021</rights><oa>free_for_read</oa><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>4</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000731207900071</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c411t-f08d1dd3395960cb470e8982742853b0c08b732454627f715a52067e5086e4273</citedby><cites>FETCH-LOGICAL-c411t-f08d1dd3395960cb470e8982742853b0c08b732454627f715a52067e5086e4273</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791099/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791099/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,315,729,782,786,887,27931,27932,39265,53798,53800</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34889419$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Turan, Ozlem</creatorcontrib><creatorcontrib>Kadir, Rezan Abdul</creatorcontrib><title>Pregnancy in special populations: challenges and solutions practical aspects of managing von Willebrand disease in pregnancy</title><title>Hematology</title><addtitle>HEMATOL-AM SOC HEMAT</addtitle><addtitle>Hematology Am Soc Hematol Educ Program</addtitle><description>Pregnancy and childbirth pose an important hemostatic challenge for women with von Willebrand disease (VWD) and can be associated with an increased risk of maternal and neonatal bleeding complications. VWD is a genetically and clinically heterogeneous bleeding disorder caused by a deficiency or an abnormality in the function of von Willebrand factor. Understanding inheritance pattern, hemostatic response to pregnancy, and response to treatment is essential for provision of individualized obstetric care and optimal outcome. A multidisciplinary approach to management with a close liaison between the obstetric team and the hemophilia treatment center is required for continuity of care from preconception counseling through to antenatal, peripartum, and postpartum care. Delivery plan must be coordinated by the multidisciplinary team and include decisions on place and mode of delivery, implementation of safe analgesia/anesthesia, and peripartum hemostasis. In this clinical case-based review, we aim to deliver evidence-based practical guidance for challenges encountered during pregnancy and management of childbirth and puerperium.</description><subject>Adult</subject><subject>Delivery, Obstetric</subject><subject>Disease Management</subject><subject>Education & Educational Research</subject><subject>Education, Scientific Disciplines</subject><subject>Female</subject><subject>Hematology</subject><subject>Humans</subject><subject>Life Sciences & Biomedicine</subject><subject>Pregnancy</subject><subject>Pregnancy Complications, Hematologic - blood</subject><subject>Pregnancy Complications, Hematologic - diagnosis</subject><subject>Pregnancy Complications, Hematologic - therapy</subject><subject>Pregnancy in Special Populations: Challenges and Solutions</subject><subject>Pregnancy Outcome</subject><subject>Science & Technology</subject><subject>Social Sciences</subject><subject>von Willebrand Diseases - blood</subject><subject>von Willebrand Diseases - diagnosis</subject><subject>von Willebrand Diseases - therapy</subject><subject>Young Adult</subject><issn>1520-4391</issn><issn>1520-4383</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>HGBXW</sourceid><sourceid>EIF</sourceid><recordid>eNqNkU9v1DAQxSMEoqXwEUA-IqEt4z-JbQ5I1YoCUiU4gDhajjPJGjl2iJOilfjwTbrtFm6cPNL83ntjvaJ4SeGcUsXe7rC3Uwqp258zYBQAOKOPilNaMtgIrvjj46zpSfEs558AVHDGnhYnXCilBdWnxZ-vI3bRRrcnPpI8oPM2kCENc7CTTzG_I25nQ8DYYSY2NiSnMN9uyDBaN3m38HYVTpmklvQ22s7HjlynSH74RVmPq6zxGW3GNWW4j3xePGltyPji7j0rvl9--Lb9tLn68vHz9uJq4wSl06YF1dCm4VyXugJXCwmotGJSMFXyGhyoWnImSlEx2Upa2uXflcQSVIWCSX5WvD_4DnPdY-MwTqMNZhh9b8e9SdabfzfR70yXro2SmoLWi8HrO4Mx_ZoxT6b32WEINmKas2EVqFKArNSClgfUjSnnEdtjDAWzNmcemjMPzS26V3_feFTdV7UAbw7Ab6xTm53H6PCILS6SUwZSr9Nqp_6f3vrptuxtmuPEbwBSg7qu</recordid><startdate>20211210</startdate><enddate>20211210</enddate><creator>Turan, Ozlem</creator><creator>Kadir, Rezan Abdul</creator><general>Amer Soc Hematology</general><general>American Society of Hematology</general><scope>BLEPL</scope><scope>DTL</scope><scope>HGBXW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20211210</creationdate><title>Pregnancy in special populations: challenges and solutions practical aspects of managing von Willebrand disease in pregnancy</title><author>Turan, Ozlem ; Kadir, Rezan Abdul</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c411t-f08d1dd3395960cb470e8982742853b0c08b732454627f715a52067e5086e4273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adult</topic><topic>Delivery, Obstetric</topic><topic>Disease Management</topic><topic>Education & Educational Research</topic><topic>Education, Scientific Disciplines</topic><topic>Female</topic><topic>Hematology</topic><topic>Humans</topic><topic>Life Sciences & Biomedicine</topic><topic>Pregnancy</topic><topic>Pregnancy Complications, Hematologic - blood</topic><topic>Pregnancy Complications, Hematologic - diagnosis</topic><topic>Pregnancy Complications, Hematologic - therapy</topic><topic>Pregnancy in Special Populations: Challenges and Solutions</topic><topic>Pregnancy Outcome</topic><topic>Science & Technology</topic><topic>Social Sciences</topic><topic>von Willebrand Diseases - blood</topic><topic>von Willebrand Diseases - diagnosis</topic><topic>von Willebrand Diseases - therapy</topic><topic>Young Adult</topic><toplevel>online_resources</toplevel><creatorcontrib>Turan, Ozlem</creatorcontrib><creatorcontrib>Kadir, Rezan Abdul</creatorcontrib><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>Web of Science - Science Citation Index Expanded - 2021</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Turan, Ozlem</au><au>Kadir, Rezan Abdul</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pregnancy in special populations: challenges and solutions practical aspects of managing von Willebrand disease in pregnancy</atitle><jtitle>Hematology</jtitle><stitle>HEMATOL-AM SOC HEMAT</stitle><addtitle>Hematology Am Soc Hematol Educ Program</addtitle><date>2021-12-10</date><risdate>2021</risdate><volume>2021</volume><issue>1</issue><spage>552</spage><epage>558</epage><pages>552-558</pages><issn>1520-4391</issn><eissn>1520-4383</eissn><abstract>Pregnancy and childbirth pose an important hemostatic challenge for women with von Willebrand disease (VWD) and can be associated with an increased risk of maternal and neonatal bleeding complications. VWD is a genetically and clinically heterogeneous bleeding disorder caused by a deficiency or an abnormality in the function of von Willebrand factor. Understanding inheritance pattern, hemostatic response to pregnancy, and response to treatment is essential for provision of individualized obstetric care and optimal outcome. A multidisciplinary approach to management with a close liaison between the obstetric team and the hemophilia treatment center is required for continuity of care from preconception counseling through to antenatal, peripartum, and postpartum care. Delivery plan must be coordinated by the multidisciplinary team and include decisions on place and mode of delivery, implementation of safe analgesia/anesthesia, and peripartum hemostasis. In this clinical case-based review, we aim to deliver evidence-based practical guidance for challenges encountered during pregnancy and management of childbirth and puerperium.</abstract><cop>WASHINGTON</cop><pub>Amer Soc Hematology</pub><pmid>34889419</pmid><doi>10.1182/hematology.2021000321</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1520-4391 |
| ispartof | Hematology, 2021-12, Vol.2021 (1), p.552-558 |
| issn | 1520-4391 1520-4383 |
| language | eng |
| recordid | cdi_webofscience_primary_000731207900071 |
| source | MEDLINE; Web of Science - Science Citation Index Expanded - 2021<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" />; PubMed Central |
| subjects | Adult Delivery, Obstetric Disease Management Education & Educational Research Education, Scientific Disciplines Female Hematology Humans Life Sciences & Biomedicine Pregnancy Pregnancy Complications, Hematologic - blood Pregnancy Complications, Hematologic - diagnosis Pregnancy Complications, Hematologic - therapy Pregnancy in Special Populations: Challenges and Solutions Pregnancy Outcome Science & Technology Social Sciences von Willebrand Diseases - blood von Willebrand Diseases - diagnosis von Willebrand Diseases - therapy Young Adult |
| title | Pregnancy in special populations: challenges and solutions practical aspects of managing von Willebrand disease in pregnancy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T02%3A34%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_webof&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pregnancy%20in%20special%20populations:%20challenges%20and%20solutions%20practical%20aspects%20of%20managing%20von%20Willebrand%20disease%20in%20pregnancy&rft.jtitle=Hematology&rft.au=Turan,%20Ozlem&rft.date=2021-12-10&rft.volume=2021&rft.issue=1&rft.spage=552&rft.epage=558&rft.pages=552-558&rft.issn=1520-4391&rft.eissn=1520-4383&rft_id=info:doi/10.1182/hematology.2021000321&rft_dat=%3Cproquest_webof%3E2608540768%3C/proquest_webof%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2608540768&rft_id=info:pmid/34889419&rfr_iscdi=true |